Skip to main content
. 2020 Nov 12;5(6):e000863. doi: 10.1136/esmoopen-2020-000863

Figure 1.

Figure 1

Soluble programmed death receptor ligand 1 (sPD-L1) detectability in (A) the overall cohort according to histology; patients with (B) glioma and (C) meningioma according to WHO grade; (D) patients with brain metastasis according to the primary tumour. The lower limit of sPD-L1 detectability was 0.05 ng/mL.